ARTICLE | Clinical News
Eladur transdur-bupivacaine: Phase II data
April 18, 2011 7:00 AM UTC
Top-line data from a double-blind, U.S. Phase II trial in 263 patients with chronic low back pain showed that 3 Eladur patches administered every 72 hours for 12 weeks missed the primary endpoint of s...